首页 | 本学科首页   官方微博 | 高级检索  
     


Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway
Affiliation:1. Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, NY 10461, USA;2. Department of Oncology, Montefiore Medical Center, New York, NY 10467, USA;3. Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84132, USA;4. Department of Neurosurgery, Huashan Hospital, Fudan University, Shanghai 200040, China;1. Department of Surgery, Sidney Kimmel Comprehensive Cancer Center and Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA;2. The Brady Urological Institute, Sidney Kimmel Comprehensive Cancer Center and Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA;3. Department of Oncology, Sidney Kimmel Comprehensive Cancer Center and Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA;1. Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts;2. Department of Medical Oncology, Harvard Medical School, Dana Farber Cancer Institute, Boston, Massachusetts;1. Department of Oncology, The Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD;2. Department of Dermatology, The Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD;3. Department of Pathology, The Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD;4. Department of Surgery, The Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD;1. Medical Oncology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale L.A. Scuro 10, 37124 Verona, Italy;2. Clinica di Oncologia Medica, AOU “Ospedali Riuniti”, Polytechnic University of the Marche Region, via Conca 71, 60126 Ancona, Italy;3. Department of Medical Oncology, University Campus Bio-Medico Roma, Oncologia Medica, Rome, Italy;4. SSD Oncologia medica Tumori Testa e Collo, Fondazione IRCCS – Istituto Nazionale dei Tumori, Via Venezian, 1, 20133 Milano, Italy;5. Department of Pathology and Diagnostic, Azienda Ospedaliera Universitaria Integrata, University of Verona, Piazzale L.A. Scuro 10, 37124 Verona, Italy;6. Department of Specialistic Clinical and Odontostomatological Sciences, Polytechnic University of Marche, 60131 Ancona, Italy;7. Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy;8. Medical Oncology, IRCCS San Matteo University Hospital Foundation, piazzale C. Golgi 19, 27100 Pavia, Italy
Abstract:
Keywords:PD-1  PD-L1  PD-L2  monoclonal antibody  human cancer  immunotherapy
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号